Melexis NV risk profile
39 Normal where most of the sector sits
Measured 1 September 2026 from MELE's filed statements. Recomputed nightly.
39 (Normal), driven by Operating pressure at 49, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 47 | Elevated | Stable | One-year price volatility — 40.5% |
| Operating pressure | 49 | Elevated | Worsening | Costs outgrowing revenue — +4.7 percentage points |
| Cash conversion | 32 | Normal | Easing | Cash conversion — 1.04x |
| Leverage and coverage | Reads total_debt, cash_and_cash_equivalents, ebitda, interest_expense, total_current_assets, total_current_liabilities and a disclosed CET1 ratio, for a bank or insurer. No reading is stored for this company. | |||
| Competitive position | 34 | Normal | Stable | R&D-intensity gap against peers — -4.9 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.